Recombinant multi-species KMT5C protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine KMT5C protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
SUV420H2 and the related enzyme SUV420H1 (MIM 610881) function as histone methyltransferases that specifically trimethylate nucleosomal histone H4 (see MIM 602822) on lysine-20 (K20) (Schotta et al., 2004 [PubMed 15145825]).[supplied by OMIM, Dec 2009]
The Alternative Names of target: Histone-lysine N-methyltransferase KMT5C,KMT5C,Kmt5c,Lysine N-methyltransferase 5C,Lysine-specific methyltransferase 5C,SUV420H2,Suppressor of variegation 4-20 homolog 2 (Su(var)4-20 homolog 2,Suv4-20h2,Suv4-20h2),Suv420h2,[histone H4]-N-methyl-L-lysine20 N-methyltransferase KMT5B,[histone H4]-lysine20 N-methyltransferase KMT5B

Target products collectionGo to KMT5C products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T68490-Ag-1/ GM-Tg-hg-T68490-Ag-2 Human KMT5C protein Human
GM-Tg-rg-T68490-Ag-1/ GM-Tg-rg-T68490-Ag-2 Rat KMT5C protein Rat
GM-Tg-mg-T68490-Ag-1/ GM-Tg-mg-T68490-Ag-2 Mouse KMT5C protein Mouse
GM-Tg-cynog-T68490-Ag-1/ GM-Tg-cynog-T68490-Ag-2 Cynomolgus/Rhesus macaque KMT5C protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T68490-Ag-1/ GM-Tg-felg-T68490-Ag-2 Feline KMT5C protein Feline
GM-Tg-cang-T68490-Ag-1/ GM-Tg-cang-T68490-Ag-2 Canine KMT5C protein Canine
GM-Tg-bovg-T68490-Ag-1/ GM-Tg-bovg-T68490-Ag-2 Bovine KMT5C protein Bovine
GM-Tg-equg-T68490-Ag-1/ GM-Tg-equg-T68490-Ag-2 Equine KMT5C protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T68490-Ag-1/ GM-Tg-hg-T68490-Ag-2; GM-Tg-rg-T68490-Ag-1/ GM-Tg-rg-T68490-Ag-2;
GM-Tg-mg-T68490-Ag-1/ GM-Tg-mg-T68490-Ag-2; GM-Tg-cynog-T68490-Ag-1/ GM-Tg-cynog-T68490-Ag-2;
GM-Tg-felg-T68490-Ag-1/ GM-Tg-felg-T68490-Ag-2; GM-Tg-cang-T68490-Ag-1/ GM-Tg-cang-T68490-Ag-2;
GM-Tg-bovg-T68490-Ag-1/ GM-Tg-bovg-T68490-Ag-2; GM-Tg-equg-T68490-Ag-1/ GM-Tg-equg-T68490-Ag-2
Products Name KMT5C protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name KMT5C
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine KMT5C protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.